Cargando…

Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults

Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 predict the development of acute kidney injury following renal insults of varied aetiology. To aid clinical interpretation, we describe the kinetics of biomarker elevations around an exposure. DESIGN: In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ostermann, Marlies, McCullough, Peter A., Forni, Lui G., Bagshaw, Sean M., Joannidis, Michael, Shi, Jing, Kashani, Kianoush, Honore, Patrick M., Chawla, Lakhmir S., Kellum, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821475/ https://www.ncbi.nlm.nih.gov/pubmed/29189343 http://dx.doi.org/10.1097/CCM.0000000000002847

Ejemplares similares

Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury
por: Joannidis, Michael, et al.
Publicado: (2019)

Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers
por: Hoste, Eric A.J., et al.
Publicado: (2014)

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
por: Kashani, Kianoush, et al.
Publicado: (2013)

Broad spectrum vasopressors: a new approach to the initial management of septic shock?
por: Chawla, Lakhmir S., et al.
Publicado: (2019)

Cell-cycle arrest and acute kidney injury: the light and the dark sides
por: Kellum, John A., et al.
Publicado: (2016)

Acute kidney injury biomarkers offer the opportunity to reduce exposure to nephrotoxic drugs
por: Ostermann, M, et al.
Publicado: (2015)

Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury
por: Prowle, John R., et al.
Publicado: (2023)

Optimizing renal replacement therapy for patients who need extracorporeal membrane oxygenation: cross-talk between two organ support machines
por: Kashani, Kianoush, et al.
Publicado: (2019)

Lung–kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup
por: Joannidis, Michael, et al.
Publicado: (2019)

Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis
por: Honore, Patrick M., et al.
Publicado: (2016)

Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study
por: Hoste, Eric, et al.
Publicado: (2020)

Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
por: Ostermann, Marlies, et al.
Publicado: (2014)

Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury
por: Heung, Michael, et al.
Publicado: (2016)

Urine TIMP2 × IGFBP7 increases 24 hours before severe AKI
por: Ostermann, M, et al.
Publicado: (2014)

External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury
por: Bagshaw, Sean M., et al.
Publicado: (2021)

Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes
por: Varrier, Matt, et al.
Publicado: (2015)

TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients
por: Gunnerson, Kyle J., et al.
Publicado: (2016)

Clinical review: Biomarkers of acute kidney injury: where are we now?
por: Ostermann, Marlies, et al.
Publicado: (2012)

Goal-directed therapy and acute kidney injury: as good as it gets?
por: Doyle, James F., et al.
Publicado: (2016)

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
por: Tumlin, James A., et al.
Publicado: (2018)

Acute kidney injury 2016: diagnosis and diagnostic workup
por: Ostermann, Marlies, et al.
Publicado: (2016)

Permissive hypofiltration
por: Chawla, Lakhmir S, et al.
Publicado: (2012)

What every Intensivist should know about COVID-19 associated acute kidney injury
por: Ostermann, Marlies, et al.
Publicado: (2020)

Fluid overload and acute kidney injury: cause or consequence?
por: Ostermann, Marlies, et al.
Publicado: (2015)

Impact of electronic-alerting of acute kidney injury: workgroup statements from the 15(th) ADQI Consensus Conference
por: Hoste, Eric A. J., et al.
Publicado: (2016)

Clinical review: Timing of renal replacement therapy
por: Joannidis, Michael, et al.
Publicado: (2011)

Renal replacement therapy: to treat, or not to treat, that is the question...
por: Joannidis, Michael, et al.
Publicado: (2013)

Blood pressure deficits in acute kidney injury: not all about the mean arterial pressure?
por: Forni, Lui G., et al.
Publicado: (2017)

Severe viral infection and the kidney: lessons learned from the H1N1 pandemic
por: Joannidis, Michael, et al.
Publicado: (2011)

Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
por: Meersch, Melanie, et al.
Publicado: (2023)

Renal recovery
por: Goldstein, Stuart L, et al.
Publicado: (2014)

Renal angina: concept and development of pretest probability assessment in acute kidney injury
por: Chawla, Lakhmir S, et al.
Publicado: (2015)

Rationale for sequential extracorporeal therapy (SET) in sepsis
por: Ronco, Claudio, et al.
Publicado: (2023)

Utilizing electronic health records to predict acute kidney injury risk and outcomes: workgroup statements from the 15(th) ADQI Consensus Conference
por: Sutherland, Scott M., et al.
Publicado: (2016)

Bioelectrical impedance vector analysis in the critically ill: cool tool or just another ‘toy’?
por: Forni, Lui G., et al.
Publicado: (2015)

Moving toward a contemporary classification of drug-induced kidney disease
por: Karimzadeh, Iman, et al.
Publicado: (2023)

Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations
por: Chindarkar, Nandkishor S., et al.
Publicado: (2015)

Quality of Care for Acute Kidney Disease: Current Knowledge Gaps and Future Directions
por: Liu, Kathleen D., et al.
Publicado: (2020)

The AKI care bundle: all bundle components are created equal—are they?
por: von Groote, Thilo C., et al.
Publicado: (2021)

Nutrients and micronutrients at risk during renal replacement therapy: a scoping review
por: Berger, Mette M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3gk2pqu91or3ibvm3m168c1fru